| Literature DB >> 34833879 |
Misael Bermúdez-Bazán1, Gustavo Adolfo Castillo-Herrera1, Judith Esmeralda Urias-Silvas1, Antonio Escobedo-Reyes2, Mirna Estarrón-Espinosa1.
Abstract
Agaves are plants used in the production of alcoholic beverages and fibers. Ever since ancient times, pre-Hispanic cultures in Mexico have used them in traditional medicine to cure different ailments. Over the years, studies of the active principles responsible for the therapeutic benefits of agaves have increased. Leaves and fibers are the main agro-wastes generated in tequila and mezcal production, while fibers are the main waste product in the textile sector. Different investigations have referred to the agro-waste from agave processing as a source of bioactive molecules called secondary metabolites (SM). Among them, phenols, flavonoids, phytosterols, and saponins have been extracted, identified, and isolated from these plants. The role of these molecules in pest control and the prospect of metabolites with the biological potential to develop novel drugs for chronic and acute diseases represent new opportunities to add value to these agro-wastes. This review aims to update the biological activities and recent applications of the secondary metabolites of the genus Agave.Entities:
Keywords: agave agro-wastes; bioactive compounds; biological activity; secondary metabolites
Mesh:
Substances:
Year: 2021 PMID: 34833879 PMCID: PMC8618589 DOI: 10.3390/molecules26226789
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Medicinal uses of the Agave genus.
| Species/Tissue | Medicinal Use | References |
|---|---|---|
| Healing and cicatrization of wounds | [ | |
| Infusions to heal respiratory infections | ||
| Healing and cicatrization of wounds from leaf gel | [ | |
| Syphilis treatment, anesthetic, headache, rheumatic pain, and broken bones | [ | |
| Treatment of gout disease, infections, and burns | [ | |
|
| Treatment for tick-borne diseases | [ |
| Stomach detoxifier and constipation | [ | |
| Antimicrobial against pathogen biota of the intestines and stomach | [ | |
|
| Antidiarrheic | [ |
| Treatment against meningitis and sciatica | [ | |
| Skin eruptions, kidney disease, and hepatic affections. It has antiparasitic and anti-hemorrhagic qualities | [ |
Biological activity of identified/isolated phytochemicals from the Agave genus.
| Specie/Tissue | Compound(s) | Biological Activity | Dose | Study Model | References |
|---|---|---|---|---|---|
|
| |||||
| Flavonoid glycosides, aglycones, phenolic acids, proanthocyanins | Stimulant expression of enzymes | - | [ | ||
| Afzlequin-4-β-quercetin; dimeric flavonoids, quercetin, kaempferol | Anticancer | IC50: 6.96 µg/mL | SK-LU-1 cells | [ | |
| Flavonoid glycosides of kaempferol, quercetin, isorhamnetin, ellagic acid hexoside | Insecticide | 10.55 µg/insect |
| [ | |
| 2,4,6-trinitrophnol, flavonoids, carboxylic acids, 2-aminomethil-propanol | Insecticide | LD50: 1035 mg/mL |
| [ | |
| Phenolic acids, flavonoid glycosides, homoisoflavonoids | Anti-inflammatory | 200 mg/kg | Wistar rats: rat paw stomach | [ | |
| Apigenin | Antifungal | IC50: 72.15; 18.83 µM | [ | ||
| p-coumaric acid, puerarin | Antidiabetic | IC50: 98.8 µM, 3.87 µM | Human α-amylase | [ | |
| Acylated glycosyl flavonoids, flavonoid glycosides, phenolic acids | Stimulant and growth protection of microgreens | - | Microgreens | [ | |
|
| |||||
| Kammogenin-pentaglucoside and tetraglycoside, Gentrogenin pentaglucoside | Anticancer | IC50 82.7, 108.4 µg/mL | HT-29 cells | [ | |
| Cantala-saponin-1 | Anti-neuroinflammatory | 5-10 mg/kg | Rat brain | [ | |
| Kammogenin-glycosides | Anticancer | 50 µg/mL | Hep-G2, CaCo-2 cells | [ | |
| Smilagenin-diglycoside | Immunomodulatory | IC50: 50 mg/mL, 0.086 mg/mL | RAW 264.7 cells | [ | |
| Glycosylated steroidal saponins | Cytotoxic | IC50: 125 µg/mL | C6 cells | [ | |
| Steroidal saponins | Antineoplastic | 50 µg/mL | Vero-cells | [ | |
| Steroidal-hexaglycosylated saponin | Anti-ulcerogenic | 100 mg/kg | Rat stomach | [ | |
| Steroidal saponins | Analgesic | 100 mg/kg | Rat stomach | [ | |
|
| |||||
| β-sitosterol-glycoside, stigmasta-3,5-dien-7-one | Immunomodulatory | 50 mg/kg | Urine, blood serum, kidney rat | [ | |
| 3- | Immunomodulatory | 50 mg/kg | Mice ear edema | [ | |
RD: repellent dose, IC50: Half maximal inhibitory concentration, LD50: Median lethal dose.
Figure 1Current phenolic acids and flavonoids identified and quantified in the Agave genus, CA = cafeic acid, GA = gallic acid, rut = rutinoside, glc = glucoside, QA: quinic acid, DHLA= 3,4-dihydroxiphenillactic acid [29,30,33,43,52,53,54].
Figure 2Current phenolic acids identified in the Agave genus.
Figure 3Current flavonoids identified and quantified in the Agave genus, glc = glucose; rut: rutinoside; gal = galactoside; rham = rhamnoside; soph = sophoroside; glu A = glucuronic acid; xil: xyloside; GA = gallic acid; gent = gentrobioside; SA = sinapic acid; FA = ferulic acid, ACU = cumaric acid; MA= mallic acid [29,30,43,49,54].
Figure 4Current phytosterols identified and isolated in the Agave genus.
Biopesticide potential of agave extracts.
| Species/Tissue | Extract | Targeted Organism | Affected Organism | Biological Activity | LD50 (mg/mL) | MI (%) | t | References |
|---|---|---|---|---|---|---|---|---|
| M | Insecticide | 8.99 µg/cm2 | 50 | 24 h | [ | |||
| HA |
|
| Insecticide | 1035 mg/L | - | 72 h | [ | |
| HA |
|
| Insecticide | 17, 46 | 51, 97 | 10 Days | [ | |
| A |
|
| Ovicide | 6 | 73.8 | 24 h | [ | |
| Hxn |
| Insecticide | 100 | 100 | 24–96 h | [ | ||
| A |
| Insecticide | 0.750 | >70 | 3 h | [ | ||
| A |
| Insecticide | 25, 50 | 70.3, 92.5 | 24, 36 h | [ | ||
| A |
| Insecticide | 4% ( | 100 | 72 h | [ | ||
| A |
| Insecticide | 10% ( | 88 | 5 Days | [ | ||
| Hxn |
|
| Insecticide | 20–40 | 90 | 24 h | [ | |
| A |
| Insecticide | - | 100 | 35–65 Days | [ | ||
| A |
| Insecticide | 0.838 | 98.75 | 24 h | [ | ||
|
| A |
| Humans | Molluscicide | 42.30 | 40.5 | 6 weeks | [ |
| M |
| Humans | Molluscicide | 40, 73 | - | 24 h | [ | |
| B |
| Humans | Molluscicide | 17, 100 | 100 | 48 h | [ | |
| A |
| Humans | Molluscicide | 65 | - | 24 h | [ | |
| A | Humans | Molluscicide | 50% mL/L | 82.5 | 7 Days | [ | ||
| A | Native mollusks | Molluscicide | 1.01 mL/L | 65 | 24 h | [ | ||
| B |
| Humans | Molluscicide | 21.9, 18.5, 16 | - | 24 h | [ | |
| A, B, E |
| Molluscicide | 35.3 g/L, 93.3, 298.6 | - | 72 h | [ | ||
| E |
| Humans | Molluscicide | 82, 101 | - | 72 h | [ | |
| A |
| Humans | Larvicide | 4.5, 6.5 | 100 | 12, 24 h | [ | |
| A, M |
| Humans | Larvicide | 86, 76, 75 | 100 | 24 h | [ | |
| A |
| Humans | Larvicide | 100 | 100 | 3–4 Days | [ | |
| Acn |
| Larvicide | 60 | 35.77 | 12 h | [ | ||
| A |
|
| Nematicide | 5, 25% ( | 90.1, 99.2 | 24, 48 h | [ | |
| A |
|
| Nematicide | 20% ( | 100 | 48 h | [ | |
| A |
|
| Nematicide | 20–40% ( | 100 | [ | ||
| Acn | Insecticide | 5% ( | 34 | 72 h | [ | |||
| A |
| Humans | Larvicide | 28.27 µg/mL | 100 | 12 h | [ |
HA: Hydroalcoholic, A: Aqueous, Hxn: n-Hexane, M: Methanolic, E: Ethanolic, Acn: Acetone, B: Butanol, MI %: Mortality index, DL50: Median lethal dose, t: time.
Antifungal potential of agave extracts.
| Species/Tissue | Extract | Target Organism | Affected Crop | Biological Activity | LD50/MIC | IG (%) | t | References |
|---|---|---|---|---|---|---|---|---|
| AM |
|
| Antifungal | - | 69.31 b | 7 days | [ | |
| M |
|
| Antifungal | 40 µg/mL | - | 4 days | [ | |
| A |
| Antifungal | 3% ( | 100 a | 10 days | [ | ||
| A |
|
| Antifungal | 28.87 | 60 a | - | [ | |
| A |
| Antifungal | - | 67.98 a | 96 h | [ | ||
| HA |
| Antifungal | - | 90 c | 7 days | [ | ||
| M |
|
| Antifungal | 11.86 | 87.73 a | 9 days | [ | |
| M |
|
| Antisporulant | - | - | 12–14 h | [ | |
| L |
|
| Antifungal | 1.70 × 104 a | 14.1 c | - | [ | |
| A |
|
| Reduce aflatoxin production | - | - | 7 days | [ | |
|
- | E | Antifungal | - | 85 c | 7 days | [ | ||
| A |
| Antifungal | 60 mg/mL | 54.33 a | 7 days | [ | ||
| A |
|
| Antifungal | 75.60 a | 3 days | [ | ||
| - | Weak antifungal | - | - | 10 days | [ | |||
| A |
| Fungal protection | - | - | 10 days | [ | ||
| AM |
|
| Antifungal | - | 64.75 b | 7 days | [ | |
| A |
| Fungal protection | - | - | 10 days | [ | ||
| A |
|
| Antisporulant | - | - | 12–14 h | [ |
LD50: Median lethal dose, % IG: Inhibition growth percentage, MIC: Minimal inhibitory concentration, E: Ethanolic, M: Methanol, A: Aqueous, L: Lanolin, HA: Hydroalcoholic, AM: Aqueous methanol, C: Cocoa butter, a: Mycelial growth inhibition, b: Hyphal growth inhibition, c: Growth inhibition.